Report top-line data from the KARE Phase 2 trial of Oral KORSUVA in atopic dermatitis
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- April 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“report top-line data for the KARE Phase 2 dose-ranging trial in atopic dermatitis in the first half of 2021”
What we found
Evidence strength A What the grades mean
Later filings state Cara announced top-line data from the KARE Phase 2 trial in April 2021, within the first half of 2021 deadline.
-
A Cara Therapeutics, Inc. 8-K filed 2021-08-09
“In April 2021, the Company announced top-line results from its Phase 2 KARE dose-ranging clinical trial of Oral KORSUVA” ✓ confirmed on the page
-
A Cara Therapeutics, Inc. 10-Q filed 2021-08-09
“In April 2021, we announced top-line data from our Phase 2 KARE clinical trial.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Top-line data from KARE Phase 2 trial in atopic dermatitis
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: subject to any delays related to the ongoing COVID-19 pandemic
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Cara Therapeutics, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-TVRD-024437 · Corrections policy